Anike Te | Chief Strategy Officer
Lucideon

Anike Te, Chief Strategy Officer, Lucideon

Anike was appointed as Chief Strategy Officer of Lucideon in 2018. She previously served on Lucideon’s Group Business Development Board and is currently a member of the Strategy Management Group. Anike is the Aegis Professor of Engineering Biology at the University of Bristol. In addition to her honorary professorship, she served on the Scientific Advisory Board of the Bristol Centre for Engineering Biology (BrisEngBio). In June 2024, Anike became the Strategic Advisor to the Chief Scientific Officer of the UK Health Security Agency. Anike is a former dentist and managed clinical trials worldwide for two leading dental implant manufacturers. She is also a Certified Internal Auditor (CIA) with a background in finance and internal controls. Anike is passionate about science and advancing treatments and diagnostics for patients through innovation.

Appearances:



Day 1: 18th March 2025 @ 11:00

Opening Panel Discussion: Assessing the impact of EU and UK relations on the European Advanced Therapies Market

Day 1: 18th March 2025 @ 15:50

Panel Discussion: Academic Translation: Advancing cutting edge technologies

last published: 05/Nov/24 17:25 GMT

back to speakers


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150